The Dying Children of Yemen

20-11-18 09:04:00,

Credit:

Hugh Macleod / IRIN/Creative Commons

Reuters reported last week on one of the many tens of thousands of preventable deaths in Yemen:

Saleh al-Faqeh held the wasted arm of his baby girl as she took her last breath on Thursday at the malnutrition ward of the main hospital in Yemen’s capital, Sanaa.

Four-month-old Hajar al-Faqeh reached the al-Sabeen hospital last week from Saada province, one of thousands of Yemeni children suffering from malnutrition in a country that has been pushed to the brink of famine by more than three years of war.

Her body lies in the same ward where another baby boy, Mohammed Hashem, died from severe hunger on the same day.

A Yemeni child dies from preventable causes every ten minutes. Opponents of the war cite this statistic frequently to convey how desperate the situation is, but it fails to capture just how horrific the conditions are for more than eleven million children and millions of adults in Yemen who are hanging on by a thread. These eleven million children in Yemen represent 80% of the country’s under-18 population, and according to UNICEF they are “facing the threat of food shortages, disease, displacement and acute lack of access to basic social services.” This is a generation that has been ravaged by war, pestilence, and famine, and the health and development of the vast majority of Yemen’s children will be seriously compromised long after the fighting stops. As large and staggering as the numbers of malnourished and starving people in Yemen are, they are inadequate measures of the harm that has been done to an entire people during three and a half years of senseless, unnecessary war.

Half of Yemen’s health care facilities are no longer functioning because they have been damaged or destroyed or because there are no longer resources to run them. The enormous needs of the civilian population are overwhelming the facilities that remain:

United Nations food chief David Beasley spotted a tiny foot sticking out from under a blanket in a hospital in Yemen that has been overwhelmed with malnourished children, so he tried to bring a smile to the face of the small patient.

 » Lees verder

Dengvaxia: 700,000 Children in the Philippines Will Suffer This Severe Vaccine Side Effect | Asia-Pacific Research

07-02-18 05:14:00,

Sanofi Pasteur announced that its dengue vaccine, Dengvaxia, may lead to more severe cases of dengue fever in some people — a warning it relayed after the vaccine was already administered to more than 700,000 children in the Philippines. Those at risk, according to Sanofi, are people who have not been previously infected by dengue virus.

Their new analysis that evaluated long-term safety and efficacy of the vaccine revealed that “in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection.”1

As a result, the Philippines has launched an investigation and convened an expert panel to figure out what to do next. Health Secretary Francisco Duque said in a news release,

“The safety of the children vaccinated is paramount, and the Health Department will need to do surveillance of those given Dengvaxia with no prior infection. It’s really a big task.”2

Nearly 4 billion people across 128 countries are at risk of infection with dengue, a viral disease spread by mosquitoes.3

Symptoms of dengue fever range from mild (or none at all) to high fever along with headache, body pain, nausea, vomiting and pain behind the eyes, with most people recovering within a week.4 A severe form of the disease, known as dengue hemorrhagic fever or severe dengue, however, is life-threatening and can lead to difficulty breathing, circulatory system failure and death. It’s this severe form of dengue that Dengvaxia vaccine may increase risks for in people who have not previously been infected with dengue.

Sanofi Claimed Long-Term Safety Studies Were Completed, Now Recommends Against Vaccination in Some

In 2015, the Philippines’ Food and Drug Administration approved Dengvaxia, the first dengue vaccine in Asia, manufactured by Sanofi Pasteur. The vaccine was intended to prevent all four dengue types in individuals from 9 to 45 years of age living in endemic areas.5 At the time, Sanofi claimed studies had been conducted “affirming the vaccine’s consistent efficacy and longer-term safety profile in a study population 9 to16 years of age.”6

The new analysis, however, is based on up to six years of clinical data evaluating the long-term safety and efficacy of Dengvaxia in those who have been infected with dengue and those who have not.

 » Lees verder

Unvaccinated Children Pose No Risk to Anyone | Light On Conspiracies – Revealing the Agenda

10-01-18 08:24:00,

Dear Legislator:

My name is Tetyana Obukhanych. I hold a PhD in Immunology. I am writing this letter in the hope that it will correct several common misperceptions about vaccines in order to help you formulate a fair and balanced understanding that is supported by accepted vaccine theory and new scientific findings.

Do unvaccinated children pose a higher threat to the public than the vaccinated?

It is often stated that those who choose not to vaccinate their children for reasons of conscience endanger the rest of the public, and this is the rationale behind most of the legislation to end vaccine exemptions currently being considered by federal and state legislators country-wide. You should be aware that the nature of protection afforded by many modern vaccines – and that includes most of the vaccines recommended by the CDC for children – is not consistent with such a statement. I have outlined below the recommended vaccines that cannot prevent transmission of disease either because they are not designed to prevent the transmission of infection (rather, they are intended to prevent disease symptoms), or because they are for non-communicable diseases. People who have not received the vaccines mentioned below pose no higher threat to the general public than those who have, implying that discrimination against non-immunized children in a public school setting may not be warranted.

IPV (inactivated poliovirus vaccine) cannot prevent transmission of poliovirus. Wild poliovirus has been non-existent in the USA for at least two decades. Even if wild poliovirus were to be re-imported by travel, vaccinating for polio with IPV cannot affect the safety of public spaces. Please note that wild poliovirus eradication is attributed to the use of a different vaccine, OPV or oral poliovirus vaccine. Despite being capable of preventing wild poliovirus transmission, use of OPV was phased out long ago in the USA and replaced with IPV due to safety concerns.

Tetanus is not a contagious disease, but rather acquired from deep-puncture wounds contaminated with C. tetani spores. Vaccinating for tetanus (via the DTaP combination vaccine) cannot alter the safety of public spaces; it is intended to render personal protection only.

While intended to prevent the disease-causing effects of the diphtheria toxin, the diphtheria toxoid vaccine (also contained in the DTaP vaccine) is not designed to prevent colonization and transmission of C.

 » Lees verder